At the University of Pennsylvania, genome researchers have created a method for analyzing concordant genomic aberrations for determining important regions for tumor progression, according to a paper in PLoS Genetics. Using a method called Multiple Sample Analysis, they used microarrays to create profiles of conserved aberrations in certain cancer types, allowing them to validate targets for cancer therapies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.